Nippon India Pharma Fund - IDCW Option

Nippon India Pharma Fund - IDCW Option - Portfolio Analysis

Portfolio Overview

As of December 31, 2025

Icon Portfolio

Asset Allocation

Equity: 97.37%Others: 2.63%
Icon Portfolio

Market Cap

Large Cap: 32.01%Mid Cap: 34.55%Small Cap: 29.97%Equity: 0.83%
Icon Portfolio

Number of stocks

36
Icon Portfolio

Top 10 Holdings

116.35% of portfolio

Market Cap of Equity

Large Cap
32.0138%
Mid Cap
34.5525%
Small Cap
29.9652%
Equity
0.8344%

Companies Allocation of Equity

Sun Pharmaceuticals Industries Ltd26.04%
Lupin Ltd14.72%
Divi's Laboratories Ltd13.16%
Cipla Ltd12.78%
Dr Reddy's Laboratories Ltd12.05%
Apollo Hospitals Enterprise Ltd11.06%
Vijaya Diagnostic Centre Ltd7.41%
Medplus Health Services Ltd7.09%
Ajanta Pharma Ltd6.43%
Sai Life Sciences Ltd5.62%

Sector Allocation of Equity

Healthcare97.37%

SIP Amount

Monthly SIP Date

Nippon India Pharma Fund - IDCW Option

Suitabilty Test For Finding this Fund is Suitable or Not for User.Suitabilty Test For Finding this Fund is Suitable or Not for User.
Is This Mutual Fund Right for You?

+10k investors used our Suitability Test to get better returns

Frequently Asked Questions

Everything You Need To Know To Get Started With Confidence

In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.